https://palisadebio.com/publication/local-bioactivation-and-efficacy-of-pali-2108-a-promising-pde4-inhibitor-prodrug-for-ulcerative-colitis-treatment/ 2026-07-28T10:12:33+00:00 https://palisadebio.com/publication/advancing-pali-2108-discovery-to-strategic-positioning/ 2026-07-28T10:12:21+00:00 https://palisadebio.com/publication/local-bioactivation-and-efficacy-of-pali-2108-a-promising-pde4-inhibitor-prodrug-for-ulcerative-colitis-treatment-2/ 2026-07-28T10:12:15+00:00 https://palisadebio.com/publication/colonic-bioactivation-and-potent-tnfa-inhibition-of-pali-2108-in-human-clinical-studies-a-promising-pde4-inhibitor-prodrug-for-the-oral-treatment-of-ulcerative-colitis/ 2026-07-28T10:11:31+00:00 https://palisadebio.com/publication/detailing-characteristics-of-fibrostenotic-crohns-disease-biology-the-potential-of-a-local-pde4-inhibitor-prodrug-to-minimize-off-target-effects-maximize-efficacy/ 2026-07-28T10:11:23+00:00 https://palisadebio.com/publication/pali-2108-a-colon-specific-pde4b-inhibitor-prodrug-reduces-ulcerative-colitis-symptoms-in-an-acute-colitis-dss-mouse-model/ 2026-07-28T10:10:40+00:00 https://palisadebio.com/publication/a-bioinformatic-approach-to-pali-2108-treatment-in-ulcerative-colitis-reveals-the-potential-for-anti-fibrotic-efficacy-with-local-pde4-inhibition-in-intestinal-fibrosis/ 2026-07-28T10:10:15+00:00 https://palisadebio.com/publication/pali-2108-a-colon-specific-pde4-inhibitor-prodrug-is-bioactivated-in-the-colon-and-reduces-colon-tissue-pde4b-in-a-dose-dependent-manner-increasing-c-amp-and-suppressing-tnf-%ce%b1-in-a-mouse-model/ 2026-07-28T10:10:09+00:00 https://palisadebio.com/publication/pali-2108-phase-1b-clinical-data/ 2026-07-28T10:09:20+00:00 https://palisadebio.com/publication/pali-2108-gut-targeted-pde4-inhibition-with-pali-2108-demonstrates-rapid-clinical-histologic-and-biomarker-improvement-in-ulcerative-colitis-translational-findings-from-a-phase-1-study/ 2026-07-28T10:09:10+00:00 https://palisadebio.com/publication/oral-locally-bioactivated-pde4-inhibitor-prodrug-pali-2108-demonstrates-rapid-clinical-histologic-and-biomarker-improvement-in-ulcerative-colitis-phase-1b-translational-findings/ 2026-07-28T10:08:58+00:00 https://palisadebio.com/publication/targeted-pde4-inhibition-using-pali-2108-prodrug-as-a-novel-therapeutic-strategy-in-fibrostenotic-crohns-disease/ 2026-07-28T10:08:49+00:00 https://palisadebio.com/publication/gut-targeted-pde4-inhibition-with-pali-2108-demonstrates-rapid-clinical-histologic-and-biomarker-improvement-in-ulcerative-colitis-translational-findings-from-a-phase-1-study/ 2026-07-28T10:06:16+00:00